Robert W. Baldwin
7Patents
6h-index
5Co-inventors
48Inventor score
Filing activity: Jun 17, 1986 → Jul 21, 1994
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4925922A | Potentiation of cytotoxic conjugates | Emerging Cross-Sectional Technologies | 103 | Expired |
| US4916213A | Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof | Emerging Cross-Sectional Technologies | 86 | Expired |
| US5512283A | Methods for the selective suppression of an immune response to dust mite der Pi | Emerging Cross-Sectional Technologies | 18 | Expired |
| US4708862A | Radioimmuno detection of human cancers using anti-tumor monoclonal antibody | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4946675A | Hepatic blocking agents | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5643572A | Methods and compositions for the modulation of host immune response to an allergen | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6042827A | Anti-idiotypic antibody induction of anti-tumor response | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.